  | LOUIS, T., Lucia, F., Cousin, F., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Visvikis, D., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Lovinfosse, P., & Hustinx, R. (19 April 2024). Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence. Scientific Reports, 14 (1), 9028. doi:10.1038/s41598-024-58551-4  Peer Reviewed verified by ORBi |
 | Lucia, F., MIEVIS, C., Jansen, N., Duysinx, B., Cousin, F., LOUIS, T., BAIWIR, M., ERNST, C., WONNER, M., Hustinx, R., Lovinfosse, P.* , & Coucke, P.*. (2024). Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience. Clinical and Translational Radiation Oncology, 100720. doi:10.1016/j.ctro.2023.100720 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., PAULUS, A., Sibille, A., VAILLANT, F., Duysinx, B., Guiot, J., & Hustinx, R. (25 March 2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 15 (7), 1968. doi:10.3390/cancers15071968 Peer Reviewed verified by ORBi |
 | Gommes, C., Louis, T., Bourgot, I., Blacher, S., Noël, A., & Maquoi, E. (2023). Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: a time-resolved grey-tone image analysis based on stochastic modelling. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.988502 Peer Reviewed verified by ORBi |
 | Lucia, F., LOUIS, T., Cousin, F., Bourbonne, V., Visvikis, D., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of [ 18 F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06510-y Peer Reviewed verified by ORBi |
 | Gillot, L., Lebeau, A., Baudin, L., POTTIER, C., Louis, T., Durré, T., Longuespée, R., Mazzucchelli, G., NIZET, C., BLACHER, S., KRIDELKA, F., & Noël, A. (14 May 2022). Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization. Cellular and Molecular Life Sciences, 79 (6), 295. doi:10.1007/s00018-022-04262-w Peer Reviewed verified by ORBi |
 | Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., LAMBERT, V., Lecomte, J.* , Noël, A.* , & Heymans, S.*. (2021). Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging, 13. doi:10.18632/aging.203035 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Bourgot, I.* , Primac, I.* , Louis, T., Noël, A., & Maquoi, E. (18 August 2020). Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Frontiers in Oncology, 10 (1488). doi:10.3389/fonc.2020.01488 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890 Peer Reviewed verified by ORBi |
 | Durré, T., Morfoisse, F., ERPICUM, C., Ebroin, M., Blacher, S., García Caballero, M., Deroanne, C., Louis, T., BALSAT, C., Van De Velde, M., Kaijalainen, S., Kridelka, F., Engelholm, L., Struman, I., Alitalo, K., Behrendt, N., Paupert, J., & Noël, A. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications, 9 (1), 5178. doi:10.1038/s41467-018-07514-1 Peer Reviewed verified by ORBi |